Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma.

Expression of the intercellular adhesion molecule-1 (CD54) as well as the mutations of p53 gene were studied in childhood Burkitt's lymphoma (BL). Expression of CD54 was identified in 6 of 15 fresh BL cases. Mutations of p53 gene, analyzed by polymerase chain reaction-single stranded chain polymorphism followed by sequencing, were found in 5 of 14 cases examined. Interestingly, all the cases with p53 mutation were CD54 negative. This high frequency of p53 mutation in the CD54 negative group prompted us to analyze the clinical features of these cases. Six of 15 cases died within 21 months after initiation of therapy and five of these were CD54 negative. In addition, four of these had p53 mutation. These results suggest that the lack of CD54 by BL cells may provide the background for the mutation of p53 gene to occur which could result in the transformation to a more aggressive phenotype.

[1]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[2]  H. Koeffler,et al.  p53 in hematologic malignancies. , 1994, Blood.

[3]  V. Rotter,et al.  Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. , 1994, Blood.

[4]  T. Yoshida,et al.  OK-432-induced enhancement of ICAM-1 expression on tumor cells positively correlates to therapeutic effects for malignant effusion. , 1994, Clinical immunology and immunopathology.

[5]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[6]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[7]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[8]  C. Bartram,et al.  Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. , 1993, Blood.

[9]  H. J. Ree,et al.  Intercellular adhesion molecule‐1 (ICAM‐1) staining of reactive and neoplastic follicles. ICAM‐1 expression of neoplastic follicle differs from that of reactive germinal center and is independent of follicular dendritic cells , 1993, Cancer.

[10]  B. Caillou,et al.  Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique. , 1993, Blood.

[11]  P. Herrlich,et al.  Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44 , 1993, The Journal of experimental medicine.

[12]  G. Brittinger,et al.  Follicular dendritic cells in non‐Hodgkin‐lymphoma express adhesion molecules complementary to ligands on neoplastic B‐cells , 1992, British journal of haematology.

[13]  T. Sano,et al.  Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. , 1992, Cancer research.

[14]  M. Maio,et al.  Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells. , 1992, Leukemia & lymphoma.

[15]  K. Bhatia,et al.  The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. , 1992, Cancer research.

[16]  K. Hayashi,et al.  Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. , 1992, Blood.

[17]  H. Hojo,et al.  Expression of leukocyte adhesion molecules (ICAM‐1/LFA‐1) related to clinical behaviour in B cell lymphomas , 1992, Hematological oncology.

[18]  R. Pieters,et al.  Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. , 1991, Leukemia.

[19]  T. Crook,et al.  p53 is frequently mutated in Burkitt's lymphoma cell lines. , 1991, The EMBO journal.

[20]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[21]  G. Gaidano,et al.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[23]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[24]  N. Kiyokawa,et al.  Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells , 1990, Clinical and experimental immunology.

[25]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[26]  E. Ishii,et al.  Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related. , 1988, Hybridoma.

[27]  Y. Ishii,et al.  Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies. , 1986, Clinical and experimental immunology.

[28]  Murphy Sb.  Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. , 1980 .

[29]  J. Ziegler.  Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. , 1977, The New England journal of medicine.

[30]  D. Burkitt,et al.  A sarcoma involving the jaws in african children , 1958, CA: a cancer journal for clinicians.

[31]  M. Asada,et al.  Clonal expansion of p53 mutant cells in leukemia progression in vitro. , 1994, Leukemia.

[32]  R. Berger,et al.  Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. , 1992, Leukemia.

[33]  J. Zucker,et al.  High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  N. Kiyokawa,et al.  Distinctive Pattern of Expression of Activation and Resting B Cell Antigens on Normal and Neoplastic Human B Cells: Immunophenotypic Heterogeneity in Some Lymphomas. , 1990, Leukemia & lymphoma.